310 related articles for article (PubMed ID: 21468919)
21. Hydrate modifications of the non-steroidal anti-inflammatory drug diclofenac sodium: Solid-state characterisation of a trihydrate form.
Bartolomei M; Rodomonte A; Antoniella E; Minelli G; Bertocchi P
J Pharm Biomed Anal; 2007 Nov; 45(3):443-9. PubMed ID: 17709225
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the physicochemical properties of KRK-701P.
Bang IJ; Kim BJ; Sohn YT
Arch Pharm Res; 2015; 38(5):834-8. PubMed ID: 25052957
[TBL] [Abstract][Full Text] [Related]
23. New solid modifications of nateglinide.
Bruni G; Berbenni V; Milanese C; Girella A; Cardini A; Lanfranconi S; Marini A
J Pharm Biomed Anal; 2010 Apr; 51(5):1054-9. PubMed ID: 20022441
[TBL] [Abstract][Full Text] [Related]
24. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
25. Solid-state interaction of stearic acid with povidone and its effect on dissolution stability of capsules.
Desai D; Kothari S; Huang M
Int J Pharm; 2008 Apr; 354(1-2):77-81. PubMed ID: 18194844
[TBL] [Abstract][Full Text] [Related]
26. Preformulation evaluation of AZD1305, an oxabispidine intended for oral and intravenous treatment.
Sigfridsson K; Lundqvist R; Ohlson K
Drug Dev Ind Pharm; 2012 Jan; 38(1):19-31. PubMed ID: 21707325
[TBL] [Abstract][Full Text] [Related]
27. Crystal modification of dipyridamole using different solvents and crystallization conditions.
Adhiyaman R; Basu SK
Int J Pharm; 2006 Sep; 321(1-2):27-34. PubMed ID: 16842943
[TBL] [Abstract][Full Text] [Related]
28. Solubility and prediction of the heat of solution of sodium naproxen in aqueous solutions.
Kim YS; Méndez del Río JR; Rousseau RW
J Pharm Sci; 2005 Sep; 94(9):1941-8. PubMed ID: 16052559
[TBL] [Abstract][Full Text] [Related]
29. Polymorphic form of piroxicam influences the performance of amorphous material prepared by ball-milling.
Naelapää K; Boetker JP; Veski P; Rantanen J; Rades T; Kogermann K
Int J Pharm; 2012 Jun; 429(1-2):69-77. PubMed ID: 22433471
[TBL] [Abstract][Full Text] [Related]
30. Crystal forms of the hydrogen oxalate salt of o-desmethylvenlafaxine.
Dichiarante E; Curzi M; Giaffreda SL; Grepioni F; Maini L; Braga D
J Pharm Pharmacol; 2015 Jun; 67(6):823-9. PubMed ID: 25644936
[TBL] [Abstract][Full Text] [Related]
31. Initial salt screening procedures for manufacturing ibuprofen.
Lee T; Wang YW
Drug Dev Ind Pharm; 2009 May; 35(5):555-67. PubMed ID: 19005918
[TBL] [Abstract][Full Text] [Related]
32. Undesired co-amorphisation of indomethacin and arginine during combined storage at high humidity conditions.
Petry I; Löbmann K; Grohganz H; Rades T; Leopold CS
Int J Pharm; 2018 Jun; 544(1):172-180. PubMed ID: 29669257
[TBL] [Abstract][Full Text] [Related]
33. Solid state of a new PDE-5 inhibitor DA-8159: characterization, dissolution, transformation.
Ryu JY; Sohn YT
Arch Pharm Res; 2012 May; 35(5):861-6. PubMed ID: 22644853
[TBL] [Abstract][Full Text] [Related]
34. Reevaluation of solubility of tolbutamide and polymorphic transformation from Form I to unknown crystal form.
Hasegawa G; Komasaka T; Bando R; Yoshihashi Y; Yonemochi E; Fujii K; Uekusa H; Terada K
Int J Pharm; 2009 Mar; 369(1-2):12-8. PubMed ID: 19026732
[TBL] [Abstract][Full Text] [Related]
35. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour.
Lai F; Sinico C; Ennas G; Marongiu F; Marongiu G; Fadda AM
Int J Pharm; 2009 May; 373(1-2):124-32. PubMed ID: 19429297
[TBL] [Abstract][Full Text] [Related]
36. Enhanced dissolution rate of simvastatin using spherical crystallization technique.
Varshosaz J; Tavakoli N; Salamat FA
Pharm Dev Technol; 2011 Oct; 16(5):529-35. PubMed ID: 20684739
[TBL] [Abstract][Full Text] [Related]
37. Exploring the solid-form landscape of pharmaceutical hydrates: transformation pathways of the sodium naproxen anhydrate-hydrate system.
Raijada D; Bond AD; Larsen FH; Cornett C; Qu H; Rantanen J
Pharm Res; 2013 Jan; 30(1):280-9. PubMed ID: 22996567
[TBL] [Abstract][Full Text] [Related]
38. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
Fini A; Cavallari C; Ospitali F
Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
[TBL] [Abstract][Full Text] [Related]
39. Recrystallization of fluconazole using the supercritical antisolvent (SAS) process.
Park HJ; Kim MS; Lee S; Kim JS; Woo JS; Park JS; Hwang SJ
Int J Pharm; 2007 Jan; 328(2):152-60. PubMed ID: 16959448
[TBL] [Abstract][Full Text] [Related]
40. Characterization of four crystal polymorphs and a monohydrate of s-bupivacaine hydrochloride (levobupivacaine hydrochloride).
Niederwanger V; Gozzo F; Griesser UJ
J Pharm Sci; 2009 Mar; 98(3):1064-74. PubMed ID: 18729201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
